Rucaparib for PARP inhibitor-pretreated ovarian cancer: A GEICO retrospective subgroup analysis from the Spanish Rucaparib Access Program

  1. Yubero, A.
  2. Estévez, P.
  3. Barquín, A.
  4. Sánchez, L.
  5. Santaballa, A.
  6. Pajares, B.
  7. Reche, P.
  8. Salvador, C.
  9. Manso, L.
  10. Márquez, R.
  11. González-Martín, A.
Aldizkaria:
Gynecologic Oncology Reports

ISSN: 2352-5789

Argitalpen urtea: 2023

Alea: 48

Mota: Artikulua

DOI: 10.1016/J.GORE.2023.101211 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus